Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab.

Autor: Arpín EC; Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Spain., Sobrino TG; Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Spain., Vivero CD; Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Spain., del Campo Amigo Jorrín M; Department of Neurology, Complejo Hospitalario de Pontevedra, Pontevedra, Spain., Regal AR; Department of Neurology, Complejo Hospitalario de Pontevedra, Pontevedra, Spain., González JP; Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Spain., Bouzas ML; Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Spain.

Publikováno v: Neurodegenerative disease management [Neurodegener Dis Manag] 2016; Vol. 6 (1), pp. 5-12.